AviadoBio

Programs

Programs Our pipeline and programs reflect our mission to deliver the future of gene therapy     Programs Pipeline FTD  Retinitis Pigmentosa Alzheimer’s and other Tauopathies...

Contact

CONTACT We’d love to hear from you. If you have an enquiry about our gene therapies, delivery systems or clinical trials please contact us using the details here For General Enquiries For Patients and...

Careers

CAREERS When you join AviadoBio, you join more than just a company, you join a dedicated team with a clear mission   Life at AviadoBio Open...

Science & Innovation

SCIENCE & Innovation Find out more about our innovative gene therapies   Science & Delivery Pipeline Delivery Publications &...

About Us

ABOUT US Learn more about our mission to transform lives and our industry-leading team About Us Leadership Team Board...

ABOUT US

Learn more about our mission to transform lives and our industry-leading team

SCIENCE & Innovation

Find out more about our innovative gene therapies

 

Programs

Our pipeline and programs reflect our mission to deliver the future of gene therapy

 

 

CAREERS

When you join AviadoBio, you join more than just a company, you join a dedicated team with a clear mission

 

CONTACT

We’d love to hear from you. If you have an enquiry about our gene therapies, delivery systems or clinical trials please contact us using the details here

A Phase 1/2 open-label clinical study to evaluate the safety and preliminary efficacy of AVB-101 in people with a genetic sub-type of frontotemporal dementia (FTD-GRN) is now open for enrollment.

Clinical Trials5